These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31138493)

  • 41. Recognition, investigation and management of mitochondrial disease.
    Davison JE; Rahman S
    Arch Dis Child; 2017 Nov; 102(11):1082-1090. PubMed ID: 28647693
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Organization for rare diseases India (ORDI) - addressing the challenges and opportunities for the Indian rare diseases' community.
    Rajasimha HK; Shirol PB; Ramamoorthy P; Hegde M; Barde S; Chandru V; Ravinandan ME; Ramchandran R; Haldar K; Lin JC; Babar IA; Girisha KM; Srinivasan S; Navaneetham D; Battu R; Devarakonda R; Kini U; Vijayachandra K; Verma IC
    Genet Res (Camb); 2014 Aug; 96():e009. PubMed ID: 25579084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mitochondrial disorders: challenges in diagnosis & treatment.
    Khan NA; Govindaraj P; Meena AK; Thangaraj K
    Indian J Med Res; 2015 Jan; 141(1):13-26. PubMed ID: 25857492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expanding Internet access for health care consumers.
    Wilkins AS
    Health Care Manage Rev; 1999; 24(3):30-41. PubMed ID: 10463105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Review of 11 national policies for rare diseases in the context of key patient needs.
    Dharssi S; Wong-Rieger D; Harold M; Terry S
    Orphanet J Rare Dis; 2017 Mar; 12(1):63. PubMed ID: 28359278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Health is primary: Family medicine for America's health.
    Phillips RL; Pugno PA; Saultz JW; Tuggy ML; Borkan JM; Hoekzema GS; DeVoe JE; Weida JA; Peterson LE; Hughes LS; Kruse JE; Puffer JC
    Ann Fam Med; 2014 Oct; 12 Suppl 1(Suppl 1):S1-S12. PubMed ID: 25352575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disorders of mitochondrial function.
    Debray FG; Lambert M; Mitchell GA
    Curr Opin Pediatr; 2008 Aug; 20(4):471-82. PubMed ID: 18622207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rare neurological diseases: a Pandora's box for neurology (an European and Italian perspective).
    Federico A
    Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S12-7. PubMed ID: 23452765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strategies for eliciting and synthesizing evidence for guidelines in rare diseases.
    Pai M; Yeung CHT; Akl EA; Darzi A; Hillis C; Legault K; Meerpohl JJ; Santesso N; Taruscio D; Verhovsek M; Schünemann HJ; Iorio A
    BMC Med Res Methodol; 2019 Mar; 19(1):67. PubMed ID: 30922227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mitochondria in health and disease.
    Chakrabarty S; Kabekkodu SP; Singh RP; Thangaraj K; Singh KK; Satyamoorthy K
    Mitochondrion; 2018 Nov; 43():25-29. PubMed ID: 29944924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 116th ENMC international workshop: the treatment of mitochondrial disorders, 14th-16th March 2003, Naarden, The Netherlands.
    Chinnery PF; Bindoff LA;
    Neuromuscul Disord; 2003 Nov; 13(9):757-64. PubMed ID: 14561500
    [No Abstract]   [Full Text] [Related]  

  • 54. Mitochondrial medicine arrives to prime time in clinical care: nutritional biochemistry and mitochondrial hyperpermeability ("leaky mitochondria") meet disease pathogenesis and clinical interventions.
    Vasquez A
    Altern Ther Health Med; 2014; 20 Suppl 1():26-30. PubMed ID: 24473983
    [No Abstract]   [Full Text] [Related]  

  • 55. Recent topics: the diagnosis, molecular genesis, and treatment of mitochondrial diseases.
    Murayama K; Shimura M; Liu Z; Okazaki Y; Ohtake A
    J Hum Genet; 2019 Feb; 64(2):113-125. PubMed ID: 30459337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseases.
    Goss CH; Mayer-Hamblett N; Kronmal RA; Ramsey BW
    Adv Drug Deliv Rev; 2002 Dec; 54(11):1505-28. PubMed ID: 12458158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coordination of care by primary care practices: strategies, lessons and implications.
    O'Malley AS; Tynan A; Cohen GR; Kemper N; Davis MM
    Res Brief; 2009 Apr; (12):1-16. PubMed ID: 19452679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitochondria in biology and medicine--2012.
    Desler C; Rasmussen LJ
    Mitochondrion; 2014 May; 16():2-6. PubMed ID: 23727386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Chinese Medical Syndrome Distribution Laws of Mitochondrial Diseases Based on Combination of Disease and Syndrome].
    Lin F; Wang J; Xiong XJ; Fan X; Jiang YW
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Nov; 36(11):1381-1384. PubMed ID: 30641636
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of a managed clinical network in oral medicine.
    Montgomery-Cranny J; Edmondson M; Reid J; Eapen-Simon S; Hegarty AM; Mighell AJ
    Br Dent J; 2017 Dec; 223(9):719-725. PubMed ID: 29097796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.